Commercialization: Page 34
-
PharmaVoice Team/PharmaVoice
CNS: Specialty Audiences
On April 29, 2016, Nuplazid (pimavanserin) became the first drug approved by the FDA for the treatment of hallucinations and delusions associated with Parkinson’s disease (PD) psychosis. Its journey from molecule to market took Acadia Pharma 17 years to complete. The company is now preparing for ...
By Robin Robinson • Sept. 1, 2016 -
PharmaVoice Team/PharmaVoice
Germany Puts Focus on Pharma Innovation
The fourth largest economy in the world and the largest in Europe, Germany remains one of the world’s economic powerhouses. Despite some uncertainty brought about by Brexit, Germany is expected to continue to withstand economic turmoil. The pharmaceutical and chemical industry combined is the cou...
By Kim Ribbink • Sept. 1, 2016 -
PharmaVoice Team/PharmaVoice
SHOWCASE FEATURE: Data Delivery Data Management
Some experts say cloud-based applications are the key to using leveraged data with sensors, and are the key to unleashing the power of the Internet of Things (IoT). IoT doesn’t function without cloud-based applications to interpret and transmit the data coming from all these sensors. The cloud is...
By Taren Grom • Sept. 1, 2016 -
PharmaVoice Team/PharmaVoice
Data, Marketing, and the Pharmaceutical Industry
It’s 2016, and we are living in an age where data is everywhere. It’s a bit like oxygen or water, data flows freely, generated by you, me, and the plethora of devices with which we interact. The planets that lined up to enable this are the ever-more powerful set of devices we possess, on-demand c...
By Ritesh Patel • Sept. 1, 2016 -
PharmaVoice Team/PharmaVoice
SHOWCASE FEATURE: Marketing in a New World
The Institute for Healthcare Improvement’s Triple Aim initiative outlines how new healthcare designs must be developed to simultaneously pursue three dimensions: improving the patient experience of care, including quality and satisfaction; improving the health of populations; and reducing the per...
By Taren Grom • Sept. 1, 2016 -
PharmaVoice Team/PharmaVoice
Healthcare Marketing: Interconnectivity of Our Target Audiences and Engagement in their Dialogue
Marketing efforts in the U.S. healthcare system are evolving almost daily. The still-unfolding Affordable Care Act (“Obamacare"), continued consolidation among pharmaceutical manufacturers, and advances in communication tools have all impacted these efforts. The ways healthcare marketers communic...
By Larry Lannino • Sept. 1, 2016 -
PharmaVoice Team/PharmaVoice
Digital Medical Media: How to Deliver an Edge to Physicians and Advertisers Alike
What is driving the trend to provide digital engagement and messaging to physicians? Increasing numbers of physicians blocked from detailing necessitating rapid growth in non-personal communications. Also, data and ability to measure return has only recently become a meaningful reality – pharma ...
By Doug Grose • Sept. 1, 2016 -
PharmaVoice Team/PharmaVoice
Staying Ahead for Patients and Physicians
The healthcare system is undergoing a profound change in how care is delivered, reimbursed, and coordinated. A new emphasis on population health, patient experience, and cost per capita has been brought about through new policy (the Affordable Care Act) and effectively articulated through the “Tr...
By Patrick Beers • Sept. 1, 2016 -
PharmaVoice Team/PharmaVoice
Attention: Outdated Access Services Strategies Actually Reduce Access
Access services aim to solve almost everything that interferes with the progression from writing prescriptions to the patients receiving their medications. Traditional emphasis has been on reimbursement barriers, solving for coverage issues as well as affordability issues. Many also include patie...
By Nora Tsvigas • Sept. 1, 2016 -
PharmaVoice Team/PharmaVoice
Pharma's New Organized Customers…Can We Connect the Dots?
Healthcare reform is rapidly moving to value-based reimbursement, prompting institutions and providers to join together and create new organizations capable of coordinating the care necessary to achieve value-based outcomes. These are the new pharma industry’s B2B customers: organized groups of i...
By John W. Draper • Sept. 1, 2016 -
PharmaVoice Team/PharmaVoice
Speak Out
A Fearless look at a workshop worth its salt When was the last time you attended a workshop or training session that felt worth the volume of unopened email and loss of billable work time? We often spend workshops checking our phones and sneaking peeks at the agenda to see when the next coffee br...
By Tara Bernardino • Sept. 1, 2016 -
PharmaVoice Team/PharmaVoice
What's New
The Bloc Launches BlocAlley Trending now: New division helps drive commercial success for entrepreneurial health organizations. The Bloc has launched BlocAlley, a new division that helps clients in the health sector launch and commercialize themselves as well as their lead products and services. ...
By PharmaVoice Team • Aug. 1, 2016 -
PharmaVoice Team/PharmaVoice
Pharma Trax
Biopharma Sponsors Sell or Plan to Sell Biosimilar Products Trending now: Industry experts project there will be a biosimilar boom. The majority of companies with a large molecule offering plan to enter or are already involved in the biosimilar market, including companies with no internal manufa...
By PharmaVoice Team • Aug. 1, 2016 -
PharmaVoice Team/PharmaVoice
Who's On The List by Section
This article contains the list of 100 honorees. If you want to read the article featuring a particular person, please view the Section in which he/she is featured. Commanders & Chiefs Julie Adrian Chandler Chicco Agency, inVentiv Health Mary Anderson Ogilvy CommonHealth Medical Educatio...
By PharmaVoice Team • Aug. 1, 2016 -
PharmaVoice Team/PharmaVoice
The Commanders & Chiefs
John W. Hubbard, Ph.D. Title: President and CEO Company: Bioclinica Education: Ph.D., Physiological Psychology and Physiology, University of Tennessee Family: Wife of 36 years Hobbies: Martial Arts, 3rd Degree Black Belt and senior instructor, international travel, home improvements, and gardenin...
By PharmaVoice Team • Aug. 1, 2016 -
PharmaVoice Team/PharmaVoice
Born Leaders A Global Perspective
This year, the homelands of the PharmaVOICE 100 account for almost 20 different countries or territories — from Russia to the West Indies, from Scotland to New Zealand, and from the United States to Australia and various points in between. Six of our honorees — Ken Keller, Stu Libby, Jennifer Mat...
By PharmaVoice Team • Aug. 1, 2016 -
PharmaVoice Team/PharmaVoice
The Entrepreneurs
Susan Flinn Cobian Title: Executive VP, Managing Director Company: HYC Health Education: BA, Kenyon College Family: Husband, Randy Robert Cobian Hobbies: Golf and paddle tennis Bucket List: To spend two weeks in Ireland and Scotland playing golf; to sing on the stage of the Grand Ole Opry; to com...
By PharmaVoice Team • Aug. 1, 2016 -
PharmaVoice Team/PharmaVoice
Bucket List
The PharmaVOICE 100 honorees have a wide range of interests. They are interested in travel, adventure, and giving back. Download PDF
By PharmaVoice Team • Aug. 1, 2016 -
PharmaVoice Team/PharmaVoice
Change Agents
Alison Little Title: Principal, Advisory Industry Leader for Life Sciences Company: KPMG LLP Education: BS, Materials Science & Engineering, Johns Hopkins University Family: Parents; husband; two children Hobbies: Cooking, yoga, spending time with family and friends Bucket List: Travel with f...
By PharmaVoice Team • Aug. 1, 2016 -
PharmaVoice Team/PharmaVoice
Alternate Universe
We asked the PharmVOICE 100 what other profession they would like to attempt. Our honorees have some fanciful and aspirational alter egos in terms of alternate professions they would, if they could, try. Download PDF
By PharmaVoice Team • Aug. 1, 2016 -
PharmaVoice Team/PharmaVoice
The Creatives
Jeffrey Perino Title: Head of Creative, Copy Company: Triple Threat Communications Education: BA, Philosophy, Loyola University; MFA, Creative Writing, Emerson College Family: Wife, Ashley; children, Michael, Julia, and Will Hobbies: Running, reading, listening to and playing classical music Soci...
By PharmaVoice Team • Aug. 1, 2016 -
PharmaVoice Team/PharmaVoice
The Marketers
Michelle Petroff Title: Senior VP, Account Service and Operations Company: Fingerpaint Education: BS, Health Policy and Administration, Pennsylvania State University Family: Her husband and her two young boys who inspire her every day Hobbies: Reading, occasional jogging, photography Awards/Honor...
By PharmaVoice Team • Aug. 1, 2016 -
PharmaVoice Team/PharmaVoice
Giving Back
The PharmaVOICE 100 honorees share a sincere desire to pay it forward. Philanthropy is a big part of what makes our inspired leaders tick. They generously give of their time and resources. Download PDF
By PharmaVoice Team • Aug. 1, 2016 -
PharmaVoice Team/PharmaVoice
The Challenges Facing Pharmaceutical Leaders
The pharmaceutical industry is at an unprecedented time in its evolution. Our PharmaVOICE 100 say the shifting influences of the patient, the payer, and technology are changing how medicines are developed and how care is delivered. The convergence of mobile technologies, diagnostics, and personal...
By PharmaVoice Team • Aug. 1, 2016 -
PharmaVoice Team/PharmaVoice
The Innovation Spark Catches Fire
Medical innovation can help patients live longer, healthier, and more productive lives. Innovative medicines developed by America’s biopharmaceutical research companies have helped increase childhood cancer survival rates from 58% in 1970 to 83% today and have contributed to declining death rates...
By PharmaVoice Team • Aug. 1, 2016
Previous
